Attributes | Values |
---|
rdf:type
| |
Description
| - Silymarin has anti-proliferative and anti-angiogenic activities in-xenografts of human prostate cancer (PCa). Low dietary selenium on the other hand has been associated with increased-incidence of PCa. The purpose of the current trial was to determine whether a daily administration of a silymarin and-selenium (SM-Se) combination for 6 months would alter basic clinical chemistry and oxidative stress markers, and-improve the quality of life score (QoL) in men after radical prostatectomy (RP). The selected combination of silymarin and selenium significantly reduced two markers of lipid metabolism-known to be associated with PCa progression, LDL and total cholesterol in the blood of men after RP. This-suggests that this combination may be effective in reducing PCa progression.
- Silymarin has anti-proliferative and anti-angiogenic activities in-xenografts of human prostate cancer (PCa). Low dietary selenium on the other hand has been associated with increased-incidence of PCa. The purpose of the current trial was to determine whether a daily administration of a silymarin and-selenium (SM-Se) combination for 6 months would alter basic clinical chemistry and oxidative stress markers, and-improve the quality of life score (QoL) in men after radical prostatectomy (RP). The selected combination of silymarin and selenium significantly reduced two markers of lipid metabolism-known to be associated with PCa progression, LDL and total cholesterol in the blood of men after RP. This-suggests that this combination may be effective in reducing PCa progression. (en)
|
Title
| - THE SAFETY AND EFFICACY OF A SILYMARIN AND SELENIUM COMBINATION IN MEN AFTER RADICAL PROSTATECTOMY A SIX MONTH PLACEBO-CONTROLLED DOUBLE-BLIND CLINICAL TRIAL
- THE SAFETY AND EFFICACY OF A SILYMARIN AND SELENIUM COMBINATION IN MEN AFTER RADICAL PROSTATECTOMY A SIX MONTH PLACEBO-CONTROLLED DOUBLE-BLIND CLINICAL TRIAL (en)
|
skos:prefLabel
| - THE SAFETY AND EFFICACY OF A SILYMARIN AND SELENIUM COMBINATION IN MEN AFTER RADICAL PROSTATECTOMY A SIX MONTH PLACEBO-CONTROLLED DOUBLE-BLIND CLINICAL TRIAL
- THE SAFETY AND EFFICACY OF A SILYMARIN AND SELENIUM COMBINATION IN MEN AFTER RADICAL PROSTATECTOMY A SIX MONTH PLACEBO-CONTROLLED DOUBLE-BLIND CLINICAL TRIAL (en)
|
skos:notation
| - RIV/61989592:15110/10:10212887!RIV11-MSM-15110___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61989592:15110/10:10212887
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Blood cholesterol; Plasma lipoproteins; Clinical chemistry; Radical prostatectomy; Prostate cancer; Selenium (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Ulrichová, Jitka
- Vostálová, Jitka
- Vidlář, Aleš
- Šimánek, Vilím
- Študent, Vladimír
- Vrbková, Jana
- Krajíček, Jiří
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |